What fills me with confidence is that Dr Sud was working on a...

First 110 Last

Share
Profile

Follow
Leigh1983

353 Posts.

54

11/07/20

13:23

Post #: 45797112
Share

Originally posted by MrFantastic: ↑

I was just thinking about the up coming ARDS ANN. I’m sure a lot of you are feeling a little nervous, as am I. The question that keeps popping up for me is this... why would they (Dr Sud and the BOD) risk the SP going down and investors losing in faith in their abilities to produce positive results on the ARDS trial if they didn’t already know it actually works? Dr Sud needs the SP to be at certain levels to make this worth while, especially after forking out the money, and putting up your well respected name. If this trial is none successful it would not bode well for himself, his team or the BOD, hence why I believe they are very confident it will be successful.

Nothing in this world apart from death is guaranteed, so we as humans we way up the risk reward factor, and this company IMO is well worth the risk!

Nothing spells confidence than a person willing to put their name on the line for what they believe in. We are only putting up money, and can make that back, but your name and your word is everything.

Good luck everyone and I hope you’re all having a fantastic weekend. And who knows, we could be one of those stocks that hit 2000% next week! Lol

Mr F.

Expand

What fills me with confidence is that Dr Sud was working on a treatment for SAARDS a few years prior too the pandemic.Its not like he's jumped on the let's get a medication/treatment for Covid 19 bandwagon.He has instead put this trial at the forefront of the company with the years of research he's been gathering as it could help save lives,if this is successful the company will be very highly regarded moving into OSA and TBI trails.

IHL Price at posting: 7.0¢ Sentiment: Hold Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

STX

Strike Energy secures $153 million for Perth Basin gas projects

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

BRX

Belararox delineates another porphyry in Argentina at Tambo South

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

FHE

Frontier Energy achieves key milestone for Waroona energy project

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

EMD

Emyria's Empax Centre chosen for mental health clinical trial